Astrana Health (NASDAQ:ASTH) Full Year 2023 Results
Main financial results
-
Revenue: 1.39 billion USD (21% increase compared to FY2022).
-
Net profit: USD 60.7 million (34% increase compared to FY2022).
-
Profit margin: 4.4% (up from 3.9% in FY2022). The increase in margin was driven by an increase in revenue.
-
EPS: USD 1.30 (up from USD 1.00 in FY2022).
All numbers shown in the chart above are for the trailing 12 month (TTM) period.
Astrana Health EPS exceeds expectations
Sales were in line with analyst forecasts. Earnings per share (EPS) exceeded analyst estimates by 9.3%.
Looking ahead, revenues are expected to increase by an average of 14% per year over the next three years, compared to a growth forecast of 6.6% for the U.S. healthcare industry.
performance of American healthcare industry.
The company's stock price is up 13% from a week ago.
balance sheet analysis
Just as investors need to consider its earnings, it's also important to consider the strength of a company's balance sheet.we have A graphical representation of Astrana Health's balance sheet and a detailed analysis of the company's financial position.
Have feedback on this article? Curious about its content? contact Please contact us directly. Alternatively, email our editorial team at Simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodologies, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
